These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21923229)

  • 1. Pharmacological treatments for personality disorders.
    Paris J
    Int Rev Psychiatry; 2011 Jun; 23(3):303-9. PubMed ID: 21923229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological treatment for patients with borderline personality disorder: practice and study results].
    Schwerthöffer D; Bäuml J; Rentrop M
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):437-43. PubMed ID: 23939557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Management of Borderline Personality Disorder and Common Comorbidities.
    Pascual JC; Arias L; Soler J
    CNS Drugs; 2023 Jun; 37(6):489-497. PubMed ID: 37256484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines.
    Pascual JC; Martín-Blanco A; Soler J; Ferrer A; Tiana T; Alvarez E; Pérez V
    Int Clin Psychopharmacol; 2010 Nov; 25(6):349-55. PubMed ID: 20838221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
    Kutcher SP; Blackwood DH
    Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials.
    Ingenhoven T; Lafay P; Rinne T; Passchier J; Duivenvoorden H
    J Clin Psychiatry; 2010 Jan; 71(1):14-25. PubMed ID: 19778496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of pharmacological treatments and real-world outcomes in borderline personality disorder.
    Lieslehto J; Tiihonen J; Lähteenvuo M; Mittendorfer-Rutz E; Tanskanen A; Taipale H
    Acta Psychiatr Scand; 2023 Jun; 147(6):603-613. PubMed ID: 37094828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice.
    Timäus C; Meiser M; Bandelow B; Engel KR; Paschke AM; Wiltfang J; Wedekind D
    BMC Psychiatry; 2019 Dec; 19(1):393. PubMed ID: 31830934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of borderline personality disorder: replacing confusion with prudent pragmatism.
    Starcevic V; Janca A
    Curr Opin Psychiatry; 2018 Jan; 31(1):69-73. PubMed ID: 29028643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S
    Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials.
    Vita A; De Peri L; Sacchetti E
    J Clin Psychopharmacol; 2011 Oct; 31(5):613-24. PubMed ID: 21869691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough?
    Bozzatello P; Rocca P; De Rosa ML; Bellino S
    Expert Opin Pharmacother; 2020 Jan; 21(1):47-61. PubMed ID: 31693423
    [No Abstract]   [Full Text] [Related]  

  • 14. State of the art in the pharmacologic treatment of borderline personality disorder.
    Feurino L; Silk KR
    Curr Psychiatry Rep; 2011 Feb; 13(1):69-75. PubMed ID: 21140245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, risk factors, and psychopharmacological management of suicidal behavior in borderline personality disorder.
    Kolla NJ; Eisenberg H; Links PS
    Arch Suicide Res; 2008; 12(1):1-19. PubMed ID: 18240030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for borderline personality disorder--current evidence and recent trends.
    Stoffers JM; Lieb K
    Curr Psychiatry Rep; 2015 Jan; 17(1):534. PubMed ID: 25413640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do patients with borderline personality disorder belong to the bipolar spectrum?
    Deltito J; Martin L; Riefkohl J; Austria B; Kissilenko A; Corless C Morse P
    J Affect Disord; 2001 Dec; 67(1-3):221-8. PubMed ID: 11869772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy in personality disorders.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2007 Jun; 45(6):15-9. PubMed ID: 17601155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interface between borderline personality disorder and bipolar spectrum disorders.
    Paris J; Gunderson J; Weinberg I
    Compr Psychiatry; 2007; 48(2):145-54. PubMed ID: 17292705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of UK and US guidelines for drug treatment in borderline personality disorder.
    Tyrer P; Silk KR
    Int Rev Psychiatry; 2011 Aug; 23(4):388-94. PubMed ID: 22026496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.